Proline-rich tyrosine kinase 2 and Src kinase signaling transduce monosodium urate crystal-induced nitric oxide production and matrix metalloproteinase 3 expression in chondrocytes

被引:60
作者
Liu, R
Lioté, F
Rose, DM
Merz, D
Terkeltaub, R
机构
[1] Vet Adm Med Ctr, San Diego, CA 92161 USA
[2] Univ Calif San Diego, San Diego, CA 92103 USA
[3] Univ Paris 07, Hop Lariboisiere, Paris, France
来源
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 01期
关键词
D O I
10.1002/art.11486
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Articular deposition of monosodium urate monohydrate (MSU) crystals may promote cartilage and bone erosion. Therefore, the aim of this study was to determine how MSU crystals stimulate chondrocytes. Methods. Nitric oxide (NO) release, and expression of inducible nitric oxide synthase (iNOS) and matrix metalloproteinase 3 (MMP-3) were assessed in cultured chondrocytes treated with MSU. MSU-induced functional signaling by specific protein kinases (p38, Src, and the focal adhesion kinase [FAK] family members proline-rich tyrosine kinase 2 [Pyk-2] and FAK) was also examined using selective pharmacologic inhibitors and transfection of kinase mutants. Results. MSU induced MMP-3 and iNOS expression and NO release in chondrocytes in a p38-dependent manner that did not require interleukin-1 (IL-1), as demonstrated by using IL-1 receptor antagonist. MSU induced rapid tyrosine phosphorylation of Pyk-2 and FAK, their adaptor protein paxillin, and interacting kinase c-Src. Pyk-2 and c-Src signaling both mediated p38 MAPK activation in response to MSU. Pyk-2 and c-Src signaling played a major role in transducing MSU-induced NO production and MMP-3 expression. But, despite the observed FAK phosphorylation, a selective pharmacologic FAK inhibitor and a FAK dominant-negative mutant both failed to block MSU-induced NO release or MMP-3 expression in parallel experiments. Conclusion. In chondrocytes, MSU crystals activate a signaling kinase cascade typically employed by adhesion receptors that involves upstream Src and FAK family activation and downstream p38 activation. In this cascade, Pyk-2, Src, and p38 kinases transduce MSU-induced NO production and MMP-3 expression. Our results identify Pyk-2 and c-Src as novel sites for potential therapeutic intervention in cartilage degradation in chronic gout.
引用
收藏
页码:247 / 258
页数:12
相关论文
共 67 条
  • [31] Johnson K, 1999, ARTHRITIS RHEUM-US, V42, P1986, DOI 10.1002/1529-0131(199909)42:9<1986::AID-ANR26>3.0.CO
  • [32] 2-O
  • [33] One of two chondrocyte-expressed isoforms of cartilage intermediate-layer protein functions as an insulin-like growth factor 1 antagonist
    Johnson, K
    Farley, D
    Hu, SL
    Terkeltaub, R
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (05): : 1302 - 1314
  • [34] Targeting Pyk2 to β1-integrin-containing focal contacts rescues fibronectin-stimulated signaling and haptotactic motility defects of focal adhesion kinase-null cells
    Klingbeil, CK
    Hauck, CR
    Hsia, DA
    Jones, KC
    Reider, SR
    Schlaepfer, DD
    [J]. JOURNAL OF CELL BIOLOGY, 2001, 152 (01) : 97 - 110
  • [35] Hyperuricemia and gout.
    Frédéric Lioté
    [J]. Current Rheumatology Reports, 2003, 5 (3) : 227 - 234
  • [36] Liu R, 2001, J LEUKOCYTE BIOL, V70, P961
  • [37] Liu R, 2000, ARTHRITIS RHEUM, V43, P1145, DOI 10.1002/1529-0131(200005)43:5<1145::AID-ANR25>3.0.CO
  • [38] 2-T
  • [39] Loeser RF, 2002, ARTHRITIS RHEUM-US, V46, pS372
  • [40] EXPRESSION OF BETA-1 INTEGRINS BY CULTURED ARTICULAR CHONDROCYTES AND IN OSTEOARTHRITIC CARTILAGE
    LOESER, RF
    CARLSON, CS
    MCGEE, MP
    [J]. EXPERIMENTAL CELL RESEARCH, 1995, 217 (02) : 248 - 257